COMMUNIQUÉ DE PRESSE publié le 15/10/2024 à 16:30, il y a 1 année 8 mois Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16 Applied DNA Sciences to participate in Maxim Healthcare Virtual Summit with CEO Dr. James A. Hayward in a fireside chat on October 16, 2024. Company overview and business focus detailed Biotechnology Company Applied DNA Sciences PCR-based DNA Technologies Maxim Healthcare Virtual Summit CEO Interview
BRÈVE publiée le 18/09/2024 à 15:05, il y a 1 année 9 mois Applied DNA retrouve sa conformité avec l'exigence de prix d'offre minimum du Nasdaq Bourse Conformité Au Nasdaq ADN Appliqué Prix De L'offre Technologies Basées Sur La PCR
BRÈVE publiée le 18/09/2024 à 15:05, il y a 1 année 9 mois Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement Nasdaq Compliance Stock Market Bid Price Applied DNA PCR-based Technologies
COMMUNIQUÉ DE PRESSE publié le 18/09/2024 à 15:00, il y a 1 année 9 mois Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement Applied DNA Sciences, Inc. regains compliance with Nasdaq minimum bid price requirement. Full details on the company's PCR-based DNA technologies and markets Biotechnology Forward-looking Statements Nasdaq Compliance Applied DNA Sciences PCR-based DNA
BRÈVE publiée le 17/09/2024 à 15:20, il y a 1 année 9 mois Applied DNA Presents Linea IVT Platform at mRNA Summit Applied DNA Sciences Linea IVT Platform MRNA Summit Kudo Biotechnology DsRNA Mitigation
BRÈVE publiée le 17/09/2024 à 15:20, il y a 1 année 9 mois Applied DNA présente la plateforme Linea IVT au mRNA Summit Sciences Appliquées De L'ADN Plateforme Linea IVT Sommet Sur L'ARNm Biotechnologie Kudo Atténuation Des ARNdb
COMMUNIQUÉ DE PRESSE publié le 17/09/2024 à 15:15, il y a 1 année 9 mois Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 3rd Annual mRNA Process Development & Manufacturing Summit Applied DNA Sciences to showcase Linea IVT platform for rapid mRNA manufacturing at mRNA events in Boston. Co-hosts seminar with Kudo Bio to demonstrate capabilities Applied DNA Sciences Linea IVT Platform MRNA Manufacturing Kudo Bio MRNA Events
BRÈVE publiée le 17/09/2024 à 15:05, il y a 1 année 9 mois Applied DNA obtient une importante commande complémentaire d'un fabricant de dispositifs de diagnostic in vitro Technologie PCR ADN Appliqué Diagnostic Du Cancer DIV Ligne ADN
BRÈVE publiée le 17/09/2024 à 15:05, il y a 1 année 9 mois Applied DNA Secures Significant Follow-on Order from IVD Manufacturer Cancer Diagnostics Linea DNA PCR Technology Applied DNA IVD
COMMUNIQUÉ DE PRESSE publié le 17/09/2024 à 15:00, il y a 1 année 9 mois Applied DNA Receives Linea DNA Follow-on Order from Global Manufacturer of IVDs for Cancer Diagnostic Application Applied DNA Sciences receives a follow-on order for Linea DNA from a global IVD manufacturer valued at over $500,000, reflecting customer commitment and recurring orders. Dr. James A. Hayward optimistic about meeting growing industry needs Applied DNA Sciences Linea DNA IVD Manufacturer Recurring Order Diagnostic Industry
Publié le 13/07/2026 à 18:00, il y a 13 heures 5 minutes CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Publié le 13/07/2026 à 18:00, il y a 13 heures 5 minutes PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Publié le 13/07/2026 à 18:00, il y a 13 heures 5 minutes THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026
Publié le 14/07/2026 à 01:45, il y a 5 heures 20 minutes Arctic Fox Lithium Approved for Trading on the OTCQB Venture Market and Announces DTC Eligibility
Publié le 14/07/2026 à 00:01, il y a 7 heures 4 minutes Captor Capital Announces Delay in its Annual Filings
Publié le 13/07/2026 à 23:10, il y a 7 heures 55 minutes Galaxy Ventures Inc. Announces Director Resignation
Publié le 13/07/2026 à 21:35, il y a 9 heures 30 minutes ATHA Energy Announces Corporate Activities Update
Publié le 13/07/2026 à 20:00, il y a 11 heures 5 minutes IBC Announces Share-Based Compensation to Directors
Publié le 14/07/2026 à 06:30, il y a 35 minutes Formycon AG and OneSource Specialty Pharma announce strategic Manufacturing Partnership for Biosimilars
Publié le 14/07/2026 à 04:45, il y a 2 heures 20 minutes Asia’s Debut of LEAP East in HKCEC Marks Hong Kong’s Largest Inaugural Tech Summit
Publié le 13/07/2026 à 22:30, il y a 8 heures 35 minutes Half-year 2026 Results Media and Investor Conference Call and Webcast
Publié le 13/07/2026 à 21:20, il y a 9 heures 45 minutes Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Publié le 13/07/2026 à 21:17, il y a 9 heures 47 minutes EQS-Adhoc: Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook